4.5 Article

Altering the specificity of NK:target cell interactions by genetic manipulation of NK receptor expression on primary mouse NK cells

Journal

VACCINE
Volume 28, Issue 22, Pages 3767-3772

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.03.013

Keywords

Lentiviral vectors; NK and immunotherapy

Funding

  1. Manitoba Health Research Council, Manitoba Institute of Child Health
  2. Natural Sciences and Engineering Research Council [RGPIN/355727-2008]
  3. Canadian Institutes of Health Research (CIHR) [FRN 74754]
  4. Manitoba Health Research Council
  5. Ontario Ministry of Research and Innovation
  6. CIHR
  7. Burroughs Wellcome Fund
  8. Manitoba Blue Cross
  9. Manitoba Medical Service Foundation

Ask authors/readers for more resources

A balance of signals generated via stimulatory and inhibitory NK receptors determines both target cell specificity and the outcome of NK-target cell interactions. The feasibility of introducing naturally occurring or genetically engineered chimeric NM receptors at the effector cell level may prove useful in NK cell-based immunotherapies. Here, we utilized a previously established lentiviral transduction system to over-express a model NKR-P1B inhibitory receptor on primary mouse NK cells. These genetically engineered NM cells became more sensitive to inhibitory signals delivered by target cells expressing the cognate NKR-P1B ligand, Ocil/Clr-b. This study demonstrated the utility of lentiviral vectors as a means to stably manipulate the target cell specificity of primary NM cells. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available